Filing Details
- Accession Number:
- 0001179110-20-008462
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-23 17:04:47
- Reporting Period:
- 2020-07-21
- Accepted Time:
- 2020-07-23 17:04:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1712233 | J Michael Pederson | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2020-07-21 | 23,008 | $0.00 | 96,899 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2020-07-21 | 23,008 | $98.00 | 73,891 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2020-07-21 | 2,437 | $99.08 | 71,454 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2020-07-21 | 23,008 | $0.00 | 23,008 | $50.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,008 | 2019-07-21 | 2027-07-20 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.